Gena Kanas
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
Papers in
-
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 1
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Fionna S. Mowat (2 shared papers)John M. Primrose (1 shared paper)Graeme John Poston (1 shared paper)Michael A. Choti (1 shared paper)Aliki Taylor (1 shared paper)Wendy Langeberg (1 shared paper)Ruben G.W. Quek (1 shared paper)Wenzhen Ge (1 shared paper)
- Journals
- Future Oncology (5 papers)Cancer Management and Research (2 papers)Breast Cancer Research and Treatment (1 paper)Clinical Epidemiology (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Gena Kanas
13 papers receiving 743 citations
Gena Kanas's Hit Papers
Peers
Comparison fields: 5 of 53
- Hepatology 296
- Oncology 241
- Hematology 82
- Pathology and Forensic Medicine 74
- Cancer Research 51
Countries citing papers authored by Gena Kanas
This map shows the geographic impact of Gena Kanas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gena Kanas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gena Kanas more than expected).
Fields of papers citing papers by Gena Kanas
This network shows the impact of papers produced by Gena Kanas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gena Kanas. The network helps show where Gena Kanas may publish in the future.
Co-authors
The 25 scholars most cited alongside Gena Kanas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors Hit paper breakdown → | 2012 | 539 |
| 2 | 2021 | 87 | |
| 3 | 2010 | 84 | |
| 4 | 2021 | 13 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 8 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 4 | |
| 9 | 2022 | 4 | |
| 10 | Use of electronic medical records (EMRs) in oncology outcomes research | 2009 | 3 |
| 11 | 2023 | 2 | |
| 12 | 2024 | 1 | |
| 13 | Use of electronic medical records in oncology outcomes research | 2010 | 1 |
| 14 | 2023 | 0 |
About Gena Kanas
Gena Kanas is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Pathology and Forensic Medicine and Hepatology, having authored 14 papers that have together received 758 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Urinary and Genital Oncology Studies (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Economic and Financial Impacts of Cancer (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Cancer Mechanisms and Therapy (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Hepatology (296 citations), Oncology (241 citations), Hematology (82 citations), Pathology and Forensic Medicine (74 citations) and Cancer Research (51 citations). Gena Kanas has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Fionna S. Mowat, John M. Primrose, Graeme John Poston, Michael A. Choti, Aliki Taylor, Wendy Langeberg, Ruben G.W. Quek, Wenzhen Ge, Jon E. Arnason and Li Lin. Their work appears in journals such as Future Oncology, Cancer Management and Research, Breast Cancer Research and Treatment, Clinical Epidemiology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.